Sing P. Chan

Array ( [id] => 6716646 [patent_doc_number] => 20030027994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'High affinity humanized anti-CEA monoclonal antibodies' [patent_app_type] => new [patent_app_number] => 09/974516 [patent_app_country] => US [patent_app_date] => 2001-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 13133 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20030027994.pdf [firstpage_image] =>[orig_patent_app_number] => 09974516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6157983 [patent_doc_number] => 20020146846 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Novel method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment' [patent_app_type] => new [patent_app_number] => 09/971543 [patent_app_country] => US [patent_app_date] => 2001-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12823 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20020146846.pdf [firstpage_image] =>[orig_patent_app_number] => 09971543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6636379 [patent_doc_number] => 20020086830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'Human apoptosis-related calcium-binding protein' [patent_app_type] => new [patent_app_number] => 09/969836 [patent_app_country] => US [patent_app_date] => 2001-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18265 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20020086830.pdf [firstpage_image] =>[orig_patent_app_number] => 09969836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5904963 [patent_doc_number] => 20020141941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'PSCA: prostate stem cell antigen and uses thereof' [patent_app_type] => new [patent_app_number] => 09/963620 [patent_app_country] => US [patent_app_date] => 2001-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 79 [patent_figures_cnt] => 79 [patent_no_of_words] => 46057 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20020141941.pdf [firstpage_image] =>[orig_patent_app_number] => 09963620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6175978 [patent_doc_number] => 20020155498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof' [patent_app_type] => new [patent_app_number] => 09/956086 [patent_app_country] => US [patent_app_date] => 2001-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 23472 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20020155498.pdf [firstpage_image] =>[orig_patent_app_number] => 09956086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5789499 [patent_doc_number] => 20020161201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof' [patent_app_type] => new [patent_app_number] => 09/956087 [patent_app_country] => US [patent_app_date] => 2001-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 23515 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20020161201.pdf [firstpage_image] =>[orig_patent_app_number] => 09956087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6554660 [patent_doc_number] => 20020164339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Recombinant peptides derived from the Mc3 anti-BA46 antibody, methods of use thereof, and methods of humanizing antibody peptides' [patent_app_type] => new [patent_app_number] => 09/956206 [patent_app_country] => US [patent_app_date] => 2001-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 19461 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20020164339.pdf [firstpage_image] =>[orig_patent_app_number] => 09956206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6721535 [patent_doc_number] => 20030055225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Monoclonal antibody for the detection of protein products of the brx gene, and uses thereof' [patent_app_type] => new [patent_app_number] => 09/953407 [patent_app_country] => US [patent_app_date] => 2001-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8240 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20030055225.pdf [firstpage_image] =>[orig_patent_app_number] => 09953407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6634701 [patent_doc_number] => 20030211570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 09/945584 [patent_app_country] => US [patent_app_date] => 2001-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 65385 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211570.pdf [firstpage_image] =>[orig_patent_app_number] => 09945584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1093477 [patent_doc_number] => 06825326 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-30 [patent_title] => 'PSCA: prostate stem cell antigen and uses thereof' [patent_app_type] => B2 [patent_app_number] => 09/934773 [patent_app_country] => US [patent_app_date] => 2001-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 90 [patent_no_of_words] => 49237 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/825/06825326.pdf [firstpage_image] =>[orig_patent_app_number] => 09934773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6111108 [patent_doc_number] => 20020172986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-21 [patent_title] => '23228, a novel human tetraspanin family member and uses thereof' [patent_app_type] => new [patent_app_number] => 09/934268 [patent_app_country] => US [patent_app_date] => 2001-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 45042 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20020172986.pdf [firstpage_image] =>[orig_patent_app_number] => 09934268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6501120 [patent_doc_number] => 20020025558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-28 [patent_title] => 'Human MAD proteins and uses thereof' [patent_app_type] => new [patent_app_number] => 09/930317 [patent_app_country] => US [patent_app_date] => 2001-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23142 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20020025558.pdf [firstpage_image] =>[orig_patent_app_number] => 09930317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5858987 [patent_doc_number] => 20020123080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-05 [patent_title] => 'Inhibiting proliferation of cancer cells' [patent_app_type] => new [patent_app_number] => 09/929552 [patent_app_country] => US [patent_app_date] => 2001-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5678 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20020123080.pdf [firstpage_image] =>[orig_patent_app_number] => 09929552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847032 [patent_doc_number] => 20030166199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Serine dehydratase homolog' [patent_app_type] => new [patent_app_number] => 09/925140 [patent_app_country] => US [patent_app_date] => 2001-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21223 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166199.pdf [firstpage_image] =>[orig_patent_app_number] => 09925140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6715899 [patent_doc_number] => 20030027247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'Compositions and methods for generating chimeric heteromultimers' [patent_app_type] => new [patent_app_number] => 09/921144 [patent_app_country] => US [patent_app_date] => 2001-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 23057 [patent_no_of_claims] => 86 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20030027247.pdf [firstpage_image] =>[orig_patent_app_number] => 09921144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6548398 [patent_doc_number] => 20020137896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Antitumor protein and gene encoding same' [patent_app_type] => new [patent_app_number] => 09/911969 [patent_app_country] => US [patent_app_date] => 2001-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4221 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137896.pdf [firstpage_image] =>[orig_patent_app_number] => 09911969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5905859 [patent_doc_number] => 20020142359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'Monoclonal antibody to CEA, conjugates comprising said antibody, and their therapeutic use in an adept system' [patent_app_type] => new [patent_app_number] => 09/910059 [patent_app_country] => US [patent_app_date] => 2001-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 34441 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20020142359.pdf [firstpage_image] =>[orig_patent_app_number] => 09910059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6813529 [patent_doc_number] => 20030073079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 09/907575 [patent_app_country] => US [patent_app_date] => 2001-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 125 [patent_figures_cnt] => 125 [patent_no_of_words] => 121594 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20030073079.pdf [firstpage_image] =>[orig_patent_app_number] => 09907575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5936910 [patent_doc_number] => 20020062009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'Monoclonal antibodies with reduced immunogenicity' [patent_app_type] => new [patent_app_number] => 09/905243 [patent_app_country] => US [patent_app_date] => 2001-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8710 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20020062009.pdf [firstpage_image] =>[orig_patent_app_number] => 09905243 [rel_patent_id] =>[rel_patent_doc_number] =>)